Professor Patrick Brennan from the University of Sydney, currently serving as CEO of detectED-X tool development company, said that the COVID-19 diagnostic tool is called CovED.
The tool will quickly analyze the patient's lung condition based on a CT scan of the lungs in which biochemical tests are only available to simply give results of viral infection and take a lot of time.
"Based on that, the medical team can effectively classify patients. After that, they will come up with a suitable treatment regimen to save the patient's life," the professor affirmed.
Leading X-ray researcher at the University of Sydney and co-founder of CovED, Professor Stuart Grieve, said that there are 3 main signs appearing on the PC lung culture screen of COVID-19 patients.
If a patient is at risk, the first sign of a viral infection is called "ground glass opacity" in which a black area appears in the lungs "like a blurred window glass".
The second sign is called "crazy paving", as Professor Grieve shares that it "sees exactly the same" - a lung patch that looks whiter than other places, indicating a higher stage of the disease.
The third sign is called a consolidation, when the lungs are filled with mucus and appear white, the air cannot enter that area.
Although only lung X-ray doctors can explain the image of a CT scan, the covert heart disease tool with CovED will help all frontline doctors, including those in the emergency department and ICU, recognize the patient's condition.
"We do not have enough medical staff to do all the tasks. That is why now, every doctor is involved and does everything," Professor Greive emphasized.
He said that this tool will also help doctors come up with a suitable treatment regimen when detecting bad signs that make it difficult for patients to recover and improve their condition.
"This is a tool that helps clinicians and healthcare professionals anywhere in the world identify and identify this disease much more effectively than before," The Age quoted Professor Brennan as saying. "We think the tool is important. It will save thousands of lives".
The diagnostic tool was developed from the detectED-X breast cancer screening tool, which Professor Brennan said gave accurate results.
The University of Sydney has negotiated with federal health officials Greg Hunt to deploy cov covid- beyond Australia. However, with the help of GE Health and Amazon, Professor Brennan hopes to make this tool popular globally.
